Skip to main content
. 2023 Jun 5;23:507. doi: 10.1186/s12885-023-11011-0

Table 2.

The relationships between CAF, EMT, CSC biomarkers and clinicopathological characteristics

FAP P χ2 CD10 P χ2 GPR77 P χ2 N-cadherin P χ2
- + - + - + - +
Gender 0.140 2.180 0.716 0.132 0.221 1.500 0.260 1.270
 Male 73 55 104 24 110 18 77 51
 Female 30 13 36 7 40 3 30 13
Age (yr) 0.793 0.069 0.228 1.451 0.417 0.660 0.327 0.959
 <65 82 53 113 22 117 18 87 48
 ≥65 21 15 27 9 33 3 20 16
Tumor location 0.725 1.319 0.339 3.363 0.255 4.057 0.930 0.449
 Lower third 51 38 74 15 74 15 55 34
 Middle third 27 14 35 6 39 2 25 16
 UGEJ 18 13 22 9 28 3 21 10
 Diffuse 7 3 9 1 9 1 6 4
Tumour size (cm) 0.002 10.049 0.006 7.695 0.152 2.049 0.159 1.985
 <5 49 16 60 5 60 5 45 20
 ≥ 5 54 52 80 26 90 16 62 44
ypT Stage <0.001 21.699 0.016 5.753 0.035 4.428 0.004 8.185
 0–2 36 3 37 2 38 1 32 7
 3–4 67 65 103 29 112 20 75 57
ypN Stage 0.001 16.972 0.034 8.689 0.118 5.872 0.032 8.834
 0 49 14 57 6 60 3 46 17
 1 20 11 26 5 26 5 20 11
 2 14 15 19 10 23 6 19 10
 3 20 28 38 10 41 7 46 17
ypTNM Stage <0.001 24.251 0.003 11.832 0.014 8.543 0.009 9.376
 I 30 2 30 2 31 1 26 6
 II 29 14 40 3 41 2 30 13
 III 44 52 70 26 78 18 51 45
Histological types 0.961 0.002 0.255 1.296 0.333 0.938 0.666 0.187
Non-low-adhesion adenocarcinoman 64 42 84 22 95 11 65 41
Low-adhesion adenocarcinoma 39 26 56 9 55 10 42 23
Lauren classification 0.150 2.077 0.006 7.441 0.618 0.249 0.827 0.048
 Intestinal 49 40 66 23 77 12 55 34
 Diffuse or Mixed 54 28 74 8 73 9 52 30
Degree of differentiation 0.031 4.671 0.116 2.476 0.064 3.436 0.774 0.082
 Well 26 8 31 3 33 1 22 12
 Moderate or Poor 77 60 109 28 117 20 85 52
Vascular or lymphatic invasion 0.016 5.843 0.327 0.959 0.075 3.178 0.200 1.643
 No 86 46 106 26 119 13 86 46
 Yes 17 22 34 5 31 8 21 18
Nerve invasion 0.029 4.746 0.219 1.513 0.367 0.814 0.172 1.868
 No 87 48 108 27 120 15 88 47
 Yes 16 20 32 4 30 6 19 17
Mandard TRG <0.001 43.852 <0.001 15.914 0.003 9.080 0.004 8.447
 1–2 55 3 57 1 57 1 45 13
 3–5 48 65 83 30 93 20 62 51
Snail1 P χ2 Twist1 P χ2 ALDH1 P χ2 LGR5 P χ2 CD44 P χ2
- + - + - + - + - +
Gender 0.092 2.838 0.624 0.241 0.086 2.941 0.301 1.068 0.760 0.094
 Male 87 41 71 57 41 87 51 77 68 60
 Female 35 8 22 21 20 23 21 22 24 19
Age (yr) 0.337 0.923 0.874 0.025 0.951 0.004 0.484 0.490 0.539 0.377
 <65 94 41 73 62 48 87 55 80 71 64
 ≥65 28 8 20 16 13 23 17 19 21 15
Tumor location 0.906 0.559 0.657 1.612 0.258 4.028 0.226 4.349 0.876 0.690
 Lower third 62 27 49 40 37 52 43 46 50 39
 Middle third 30 11 21 20 13 28 15 26 20 21
 UGEJ 22 9 19 12 7 24 9 22 17 14
 Diffuse 8 2 4 6 4 6 5 5 5 5
Tumour size (cm) 0.360 0.837 0.002 9.315 0.789 0.071 0.840 0.041 0.112 2.526
 <5 49 16 45 20 24 41 28 37 40 25
 ≥ 5 73 33 48 58 37 69 44 62 52 54
ypT Stage 0.037 4.352 <0.001 25.461 0.240 1.380 0.039 4.241 0.067 3.364
 0–2 33 6 35 4 17 22 22 17 26 13
 3–4 89 43 58 74 44 88 50 82 66 66
ypN Stage 0.606 1.842 0.060 7.399 0.203 4.601 0.986 0.147 0.382 3.066
 0 48 15 42 21 27 36 26 37 32 31
 1 23 8 17 14 13 18 14 17 21 10
 2 19 10 14 15 9 20 12 17 14 15
 3 32 16 20 28 12 36 20 28 25 23
ypTNM Stage 0.193 3.294 <0.001 23.236 0.194 3.279 0.198 3.243 0.307 2.360
 I 27 5 29 3 15 17 18 14 21 11
 II 29 14 24 19 17 26 17 26 23 20
 III 66 30 40 56 29 67 37 59 48 48
Histological types 0.107 2.598 0.669 0.183 0.551 0.355 0.906 0.014 0.745 0.106
Non-low-adhesion adenocarcinoman 71 35 59 47 36 70 45 61 56 50
Low-adhesion adenocarcinoma 51 14 34 31 25 40 27 38 36 29
Lauren classification 0.011 6.442 0.460 0.546 0.576 0.312 0.443 0.588 0.035 4.466
 Intestinal 56 33 46 43 30 59 35 54 41 48
 Diffuse or Mixed 66 16 47 35 31 51 37 45 51 31
Degree of differentiation 0.753 0.099 0.034 4.491 0.251 1.319 0.009 6.729 0.512 0.431
 Well 25 9 24 10 15 19 21 13 20 14
 Moderate or Poor 97 40 69 68 46 91 51 86 72 65
Vascular or lymphatic invasion 0.462 0.541 0.419 0.654 0.137 2.216 0.103 2.663 0.276 1.189
 No 96 36 74 58 51 81 60 72 74 58
 Yes 26 13 19 20 10 29 12 27 18 21
Nerve invasion 0.777 0.081 0.827 0.048 0.650 0.206 0.660 0.194 0.539 0.377
 No 97 38 74 61 47 88 58 77 71 64
 Yes 25 11 19 17 14 22 14 22 21 15
Mandard TRG 0.006 7.410 <0.001 35.825 0.033 4.527 0.002 9.821 0.012 6.379
 1–2 49 9 50 8 27 31 34 24 39 19
 3–5 73 40 43 70 34 79 38 75 53 60

UGEJ Upper third and gastroesophageal junction